Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

@article{Durham2006SublingualIW,
  title={Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.},
  author={Stephen R. Durham and William H. Yang and Martin Rud Pedersen and Niels Johansen and Sabina Rak},
  journal={The Journal of allergy and clinical immunology},
  year={2006},
  volume={117 4},
  pages={802-9}
}
BACKGROUND Specific immunotherapy is the only treatment modality that has the potential to alter the natural course of allergic diseases. Sublingual immunotherapy has been developed to facilitate access to this form of treatment and to minimize serious adverse events. OBJECTIVE To investigate the efficacy and safety of sublingual grass allergen tablets in seasonal allergic rhinoconjunctivitis. METHODS A multinational, multicenter, randomized, placebo-controlled trial conducted during 2002… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 192 extracted citations

Similar Papers

Loading similar papers…